DNM1L and atherosclerosis: In the ApoE-knockout diabetic mouse model, Drp1-mediated mitochondrial fission inhibition through AMPK activation improves endothelial dysfunction and delays atherosclerosis (Wang et al., 2017; Liu et al., 2019).